We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Data Deletions, Investigation Lapses Draw Warning for Hebei Yuxing Bio-Engineering
Data Deletions, Investigation Lapses Draw Warning for Hebei Yuxing Bio-Engineering
Hebei Yuxing Bio-Engineering, a Chinese producer of active pharmaceutical ingredients, received a warning letter from the FDA citing significant cGMP and data integrity issues discovered at its manufacturing plant.